Liptorâ„¢ 10: Each film-coated tablet contains Atorvastatin Calcium USP equivalent to Atorvastatin 10 mg.
Liptorâ„¢ 20: Each film-coated tablet contains Atorvastatin Calcium USP equivalent to Atorvastatin 20 mg.
Liptorâ„¢ 40: Each film-coated tablet contains Atorvastatin Calcium USP equivalent to Atorvastatin 40 mg.
Liptorâ„¢ (Atorvastatin) is a synthetic lipid-lowering agent. Atorvastatin is an inhibitor of 3-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA) reductase. This enzyme catalyzes the conversion of HMG-CoA to mevalonate, an early and rate-limiting step of cholesterol biosynthesis.
Liptorâ„¢ is indicated as an adjunct to diet to reduce elevated total-C, LDL-C, apo B, and TG levels and to increase HDL-C in patients with primary hypercholesterolemia (heterozygous familial and nonfamilial) and mixed dyslipidemia.
OR AS DIRECTED BY THE PHYSICIAN.
Administration of Atorvastatin may show drug interaction with the following agents: Antacid, Colestipol, Digoxin, Erythromycin, Oral Contraceptives.
Overdose:
There is no specific treatment for Atorvastatin overdosage. In the event of an overdose, the patient should be treated symptomatically, and supportive measures instituted as required.
Pregnancy Category X: Safety in pregnant women has not been established. Atorvastatin is contraindicated during pregnancy and in nursing mothers. If the patient becomes pregnant while taking this drug, therapy should be discontinued.
Safety and effectiveness in patients 10-17 years of age with heterozygous familial hypercholesterolemia have been evaluated in a controlled clinical trial of 6 months’ duration in adolescent boys and postmenarchal girls. Patients treated with LIPITOR had an adverse experience profile generally similar to that of patients treated with placebo.
General:
Before instituting therapy with Atorvastatin, an attempt should be made to control hypercholesterolemia with appropriate diet, exercise, and weight reduction in obese patients, and to treat other underlying medical problems.
Information for patients:
Patients should be advised to report promptly unexplained muscle pain, tenderness, or weakness, particularly if accompanied by malaise or fever.
Store below 30°C temperature and dry place, protected from light. Keep all medicines out of reach of children.